Piramal Enterprises Ltd.
Snapshot View

845.60 -12.15 ▼-1.4%

07 October 2022, 04:01:00 PM
Volume: 51,710

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.piramal.com
Market Cap 20,155.15 Cr.
Enterprise Value(EV) 68,737.63 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 78.76 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 10.72 Trailing Twelve Months Ending 2022-06
Industry PE 32.07 Trailing Twelve Months Ending 2022-06
Book Value / Share 1,500.27 Trailing Twelve Months Ending 2022-06
Price to Book Value 0.56 Calculated using Price: 844.50
Dividend Yield 3.91 Period Ending 2022-03
No. of Shares Subscribed 23.87 Cr. 238,663,700 Shares
FaceValue 2
Company Profile
Piramal Enterprises Limited (PEL) is one of India's leading diversified companies, with a presence in Financial Services and Pharmaceuticals. Driven by both organic as well as inorganic strategy, PEL has steered dynamic business growth over the three decades of its existence.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-1.42%
1 Week
-2.13%
1 Month
-17.81%
3 Month
-50.83%
6 Month
-64.08%
1 Year
-70.70%
2 Year
-35.88%
5 Year
-67.78%
10 Year
+85.15%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -4.96 25.55 5.76 7.78 23.36 4.26 -3.61 3.33 3.87
Return on Capital Employed (%) 3.30 18.70 7.19 8.96 8.52 7.93 8.00 10.03 7.71
Return on Assets (%) -2.01 10.59 2.35 2.46 7.62 1.41 -1.26 1.33 1.42

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 10,724 9,321 11,736 12,948 14,883 26,562 27,224 30,572 34,018 35,489
Non Curr. Liab. 1,598 6,710 7,817 11,760 18,776 25,355 29,033 24,454 34,163 50,386
Curr. Liab. 11,765 9,490 5,694 10,542 18,962 22,479 31,213 23,673 13,873 19,576
Minority Int. 12 29 0 13 12 9 1,121 1,348
Equity & Liab. 24,099 25,521 25,276 35,250 52,634 74,409 87,480 78,699 83,175 106,799
Non Curr. Assets 16,398 21,149 19,912 30,595 43,471 61,843 75,089 62,586 62,782 81,611
Curr. Assets 7,701 4,372 5,364 4,655 9,163 12,566 12,390 16,113 20,393 25,188
Misc. Exp. not W/O
Total Assets 24,099 25,521 25,276 35,250 52,634 74,409 87,480 78,699 83,175 106,799

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 4,503 5,123 6,342 8,504 10,631 13,215 13,068 12,809 13,993 14,633
Other Income 225 255 252 234 264 317 500 364 720 795
Total Income 4,728 5,377 6,593 8,737 10,895 13,532 13,569 13,173 14,713 15,428
Total Expenditure -3,868 -4,238 -4,649 -5,005 -5,476 -6,573 -6,810 -5,345 -7,543 -8,137
PBIDT 860 1,140 1,944 3,733 5,419 6,959 6,758 7,828 7,170 7,292
Interest -1,050 -511 -974 -2,031 -2,978 -4,100 -5,321 -4,209 -4,480 -4,609
Depreciation -247 -290 -255 -382 -477 -401 -520 -561 -666 -702
Taxation -63 -345 -50 -228 2,876 -861 -1,960 -2,043 -511 -533
Exceptional Items 1 2,696 46 -10 -452 59 -168 -153
PAT -498 2,690 711 1,082 4,840 1,145 -1,043 1,074 1,346 1,294
Minority Interest -1 0 0 1 3 3 -81 -76 -71
Share Associate -3 159 194 170 280 319 490 338 653 657
Other Related Items
Consolidated Net Profit -501 2,850 905 1,252 5,121 1,467 24 1,332 1,923 1,880
Adjusted EPS -28 160 51 70 277 78 1 59 81 79

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -1,570 -1,604 -2,207 -6,956 -10,057 -15,967 -11,611 7,516 3,665 8,750
Cash Fr. Inv. -1,664 1,483 6,177 -604 -2,403 -1,768 -827 7,469 -2,772 -2,226
Cash Fr. Finan. 3,281 126 -3,865 7,544 13,570 18,650 10,752 -13,019 2,072 -6,988
Net Change 46 4 106 -16 1,111 916 -1,686 1,966 2,964 -465
Cash & Cash Eqvt 269 325 447 227 1,364 2,301 623 2,612 5,582 6,282

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 46.06 46.06 46.06 46.06 43.52 43.51 43.49 43.49 43.49
Public 53.94 53.95 53.94 53.94 56.48 56.49 56.51 56.51 56.51
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Mon, 03 Oct 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Thu, 29 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Wed, 28 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015

Technical Scans View Details >>

Thu, 06 Oct 2022
Close Crossing Last Month Close from Above Close Crossing Last Month Close from Above
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 1 Month High Decrease 1 Month
High Decrease 3 Months High Decrease 3 Months
High Decrease 6 Months High Decrease 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 228,896.56 953.00 -0.1%
Divi's Laboratories Ltd. 99,171.10 3,738.70 +0.0%
Cipla Ltd. 91,534.16 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. 73,236.99 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. 63,161.01 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. 54,354.34 1,566.00 -2.3%
Zydus Lifesciences Ltd. 42,831.42 421.75 -0.3%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.85 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 31.94 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 36.78 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.49 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.49 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 67.86 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 9.69 421.75 -0.3%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.57 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-06 7.98 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-06 4.26 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.62 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.63 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.50 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-06 2.55 421.75 -0.3%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 0.04 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 0.25 421.75 -0.3%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 13.10 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15.51 421.75 -0.3%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 15,265.20 421.75 -0.3%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 953.00 -0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,738.70 +0.0%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,131.75 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,372.95 -0.6%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,395.95 +0.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,566.00 -2.3%
Zydus Lifesciences Ltd. Consolidated 2022-03 2,326.40 421.75 -0.3%

FAQ's On Piramal Enterprises Ltd.

What is Piramal Enterprises share price?

Can I buy Piramal Enterprises shares now?

What is the Dividend Yield of Piramal Enterprises?

What is the Market Cap of Piramal Enterprises?

What are the key metrics to analyse Piramal Enterprises?

What is the 52 Week High and Low of Piramal Enterprises?

What is the trend of Piramal Enterprises share price?